KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Esperion Therapeutics (ESPR) Inventory: 2020-2024

Historic Inventory for Esperion Therapeutics (ESPR) over the last 5 years, with Dec 2024 value amounting to $94.5 million.

  • Esperion Therapeutics' Inventory rose 35.50% to $108.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $108.5 million, marking a year-over-year increase of 35.50%. This contributed to the annual value of $94.5 million for FY2024, which is 43.99% up from last year.
  • Latest data reveals that Esperion Therapeutics reported Inventory of $94.5 million as of FY2024, which was up 43.99% from $65.6 million recorded in FY2023.
  • Esperion Therapeutics' 5-year Inventory high stood at $94.5 million for FY2024, and its period low was $16.1 million during FY2020.
  • Moreover, its 3-year median value for Inventory was $65.6 million (2023), whereas its average is $65.1 million.
  • Data for Esperion Therapeutics' Inventory shows a peak YoY skyrocketed of 113.15% (in 2021) over the last 5 years.
  • Yearly analysis of 5 years shows Esperion Therapeutics' Inventory stood at $16.1 million in 2020, then soared by 113.15% to $34.4 million in 2021, then climbed by 2.35% to $35.2 million in 2022, then surged by 86.42% to $65.6 million in 2023, then soared by 43.99% to $94.5 million in 2024.